Results 151 to 160 of about 120,449 (305)
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Jakob Veeser +11 more
wiley +1 more source
Phase 1 Dose Escalation of Single‐Agent Mechlorethamine in Dogs With Lymphoma
ABSTRACT Mechlorethamine is commonly prescribed to dogs at 3 mg/m2. The minimal toxicity observed indicates that higher doses of mechlorethamine are likely tolerable. The primary objective of this study was to determine the maximally tolerated dose (MTD) of mechlorethamine in dogs with lymphoma.
Laura E. Chadsey +2 more
wiley +1 more source
Potentiation of the Vincristine Effect on P388 Mouse Leukemia Cells by a Newly Synthesized Dihydropyridine Analogue, PAK‐200 [PDF]
Norimasa Shudo +6 more
openalex +1 more source
ABSTRACT Cancer is a leading cause of mortality in older dogs. Despite the prevalence of chemotherapy in canine oncology, a good understanding of owners' observations of side effects and clinical signs in real time is still lacking. Owners' perceptions and reporting of clinical signs play an important role in monitoring a dog's condition during ...
Jenny Harris +5 more
wiley +1 more source
P05.45 Hydroxyurea (HU) or VAC (vincristine, adriamycin and cyclophosphamide) in a group of recurrent meningioma patients [PDF]
Antonio Silvani +5 more
openalex +1 more source
Supplementary Figure 5 from Vincristine Enhances the Efficacy of MEK Inhibitors in Preclinical Models of KRAS-mutant Colorectal Cancer [PDF]
Susmita Ghosh +12 more
openalex +1 more source
Outcome and Toxicity Profile of Stereotactic Body Radiation Therapy for Adrenal Tumours in Dogs
ABSTRACT Stereotactic body radiation therapy (SBRT) has become a non‐invasive alternative option for canine adrenal tumours with high surgical risks; however, its clinical benefits and risks are still to be fully understood. The goal of this multi‐institutional retrospective study was to describe the clinical outcome and safety of SBRT for the ...
Lily Thorsen +9 more
wiley +1 more source
Kaposiform Hemangioendothelioma of Abdominal Wall Associated with Kasabach-Merritt in A Newborn with Dramatic Response to Sirolimus and Vincristine [PDF]
Samin Alavi
openalex +1 more source
ABSTRACT A 3‐year‐old, intact female Havanese dog was presented for treatment of a relapse of suspected immune‐mediated anemia and thrombocytopenia. Over the course of treatment, the patient's anemia appeared to acutely transition from macrocytic and hypochromic to microcytic and hypochromic between days five and six of hospitalization.
Hannah R. Cohen +5 more
wiley +1 more source

